OS | Univariate analysis | Multivariate analyses | ||||
---|---|---|---|---|---|---|
Patients, n | Median survial time | P-value | HR | 95% CI | P-value | |
Gender | Â | Â | 0.153 | Â | Â | Â |
 Male/Female | 67/18 | 15/12 |  |  |  |  |
Age | Â | Â | 0.4 | Â | Â | Â |
  ≤ 60/> 60 | 38/47 | 14/13 |  |  |  |  |
Tumor location | Â | Â | 0.771 | Â | Â | Â |
 head/body or tail | 67/18 | 14/12 |  |  |  |  |
Tumor size | Â | Â | 0.165 | Â | Â | Â |
  ≤ 2/> 2 | 57/28 | 13/16 |  |  |  |  |
Neural invasion | Â | Â | 0.345 | Â | Â | Â |
 Yes/No | 33/52 | 14/14 |  |  |  |  |
Duodenal invasion |  |  | 0.005 | 2.535 | 1.316–4.884 | 0.005 |
 Yes/No | 12/73 | 10/16 |  | |||
Differentiation | Â | Â | 0.585 | Â | Â | Â |
 Low/Median/High | 19/57/9 | 14/14/18 |  |  |  |  |
Lymphatic invasion | Â | Â | 0.184 | Â | Â | Â |
 Yes/No | 31/54 | 11/16 |  |  |  |  |
Vascular invasion | Â | Â | 0.032 | Â | Â | 0.187 |
 Yes/No | 21/64 | 13/16 |  |  |  | |
TNM, | Â | Â | 0.015 | Â | Â | 0.284 |
 I, IIA/ IIB, III or IV | 39/46 | 11/16 |  |  |  | |
circ-ASH2L |  |  | 0.025 | 1.741 | 1.075–2.821 | 0.024 |
 High/Low | 42/43 | 12/16 |  |